Sheppard Mullin advised ThinkEquity on the transaction. BioVie Inc executed its $21 million public offering of Common Stock and Warrants. ThinkEquity acted as placement agent in the...
BioVie’s $21 Common Stock Offering
SmartBear’s Acquisition of Reflect Software
Fenwick & West represented Reflect Software in the transaction. A provider of software testing and visibility solutions, SmartBear announced its acquisition of SmartReflect Software, an AI-powered...
Insight Enterprises’ Acquisition of SADA
Snell & Wilmer represented Insight Enterprises in the transaction, and Fenwick & West represented SADA. Insight Enterprises (NASDAQ:NSIT) announced it has completed the acquisition of SADA, a leading cloud...
OrsoBio’s $60 Million Series A Financing Round
Fenwick & West represented OrsoBio in the transaction. OrsoBio, Inc. announced its $60 million Series A financing, bringing the total capital raised by the Company to $97 million....
DaySmart’s Acquisition of Sawyer
Fenwick & West represented Sawyer in the transaction. DaySmart Software announced its acquisition of Sawyer, a provider of business management software for the children’s activities end market....
CISCO’s $150 Million Acquisition of Working Group TwoCISCO’s $150 Million Acquisition of Working Group Two
Fenwick & West LLP represented CISCO Systems, Inc. in the transaction. CISCO Systems, Inc. (NASDAQ: CSCO) announced its pending acquisition of Working Group Two (WG2). The acquisition...
Cisco’s Acquisition of Code BGP
Fenwick & West represented CISCO Systems, Inc. in the transaction. CISCO Systems, Inc. (NASDAQ: CSCO) announced it has acquired Code BGP, a privately held BGP monitoring company based...
Novartis AG’s Acquisition of Chinook Therapeutics
Fenwick & West LLP represented Chinook Therapeutics, Inc. on the transaction, while Hogan Lovells US LLP represented Novartis AG. Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company, announced...
Morphic Therapeutic’s $276 Million Public Offering
Fenwick represented Morphic Holding, Inc. on the deal. Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment...
Cisco’s Acquisition of Valtix
Fenwick advised Cisco Systems, Inc. on the deal. Cisco Systems, Inc. (NASDAQ: CSCO), a worldwide leader in technology, announced its pending acquisition of Valtix, a privately...
IBM’s Acquisition of NS1
Fenwick advised NS1 on the deal. NS1, a provider of network automation SaaS solutions that are designed to enable businesses to deliver content, services and applications...
Shockwave Medical’s Pending Acquisition of Neovasc
Fenwick advised Shockwave Medical, Inc. on the deal. Shockwave Medical, Inc. (NASDAQ: SWAV), a medical device company focused on the development of Intravascular Lithotripsy (IVL) to...